A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery
Objectives: Coronary artery bypass grafting (CABG) success is reduced by graft occlusion. Understanding factors associated with graft occlusion may improve patient outcomes. The aim of this study was to develop a predictive risk score for saphenous vein graft (SVG) occlusion after CABG.Methods: This...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.670045/full |
id |
doaj-e2a37b6220994f14b13b62381dc869bb |
---|---|
record_format |
Article |
spelling |
doaj-e2a37b6220994f14b13b62381dc869bb2021-08-12T06:21:28ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-08-01810.3389/fcvm.2021.670045670045A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft SurgeryYujing ChengXiaoteng MaXiaoli LiuYingxin ZhaoYan SunDai ZhangQi ZhaoYingkai XuYujie ZhouObjectives: Coronary artery bypass grafting (CABG) success is reduced by graft occlusion. Understanding factors associated with graft occlusion may improve patient outcomes. The aim of this study was to develop a predictive risk score for saphenous vein graft (SVG) occlusion after CABG.Methods: This retrospective cohort study enrolled 3,716 CABG patients from January 2012 to March 2013. The development cohort included 2,477 patients and the validation cohort included 1,239 patients. The baseline clinical data at index CABG was analyzed for their independent impact on graft occlusion in our study using Cox proportional hazards regression. The predictive risk scoring tool was weighted by beta coefficients from the final model. Concordance (c)-statistics and comparison of the predicted and observed probabilities of predicted risk were used for discrimination and calibration.Results: A total of 959 (25.8%) out of 3,716 patients developed at least one late SVG occlusion. Significant risk factors for occlusion were female sex [beta coefficients (β) = 0.52], diabetes (β = 0.21), smoking (currently) (β = 0.32), hyperuricemia (β = 0.22), dyslipidemia (β = 0.52), prior percutaneous coronary intervention (PCI) (β = 0.21), a rising number of SVG (β = 0.12) and lesion vessels (β = 0.45). On-pump surgery (β = −0.46) and the use of angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) (β = −0.59) and calcium channel blockers (CCB) (β = −0.23) were protective factors. The risk scoring tool with 11 variables was developed from the derivation cohort, which delineated each patient into risk quartiles. The c-statistic for this model was 0.71 in the validation cohort.Conclusions: An easy-to-use risk scoring tool which included female sex, diabetes, smoking, hyperuricemia, dyslipidemia, prior PCI, a rising number of SVG and lesion vessels, on-pump surgery, the use of ACEI/ ARB and CCB was developed and validated. The scoring tool accurately estimated the risk of late SVG occlusion after CABG (c-statistic = 0.71).https://www.frontiersin.org/articles/10.3389/fcvm.2021.670045/fullcoronary artery bypass graftingcoronary artery diseasegraft occlusionsaphenous veinrisk factor |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yujing Cheng Xiaoteng Ma Xiaoli Liu Yingxin Zhao Yan Sun Dai Zhang Qi Zhao Yingkai Xu Yujie Zhou |
spellingShingle |
Yujing Cheng Xiaoteng Ma Xiaoli Liu Yingxin Zhao Yan Sun Dai Zhang Qi Zhao Yingkai Xu Yujie Zhou A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery Frontiers in Cardiovascular Medicine coronary artery bypass grafting coronary artery disease graft occlusion saphenous vein risk factor |
author_facet |
Yujing Cheng Xiaoteng Ma Xiaoli Liu Yingxin Zhao Yan Sun Dai Zhang Qi Zhao Yingkai Xu Yujie Zhou |
author_sort |
Yujing Cheng |
title |
A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery |
title_short |
A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery |
title_full |
A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery |
title_fullStr |
A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery |
title_full_unstemmed |
A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery |
title_sort |
novel risk scoring tool to predict saphenous vein graft occlusion after cardiac artery bypass graft surgery |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cardiovascular Medicine |
issn |
2297-055X |
publishDate |
2021-08-01 |
description |
Objectives: Coronary artery bypass grafting (CABG) success is reduced by graft occlusion. Understanding factors associated with graft occlusion may improve patient outcomes. The aim of this study was to develop a predictive risk score for saphenous vein graft (SVG) occlusion after CABG.Methods: This retrospective cohort study enrolled 3,716 CABG patients from January 2012 to March 2013. The development cohort included 2,477 patients and the validation cohort included 1,239 patients. The baseline clinical data at index CABG was analyzed for their independent impact on graft occlusion in our study using Cox proportional hazards regression. The predictive risk scoring tool was weighted by beta coefficients from the final model. Concordance (c)-statistics and comparison of the predicted and observed probabilities of predicted risk were used for discrimination and calibration.Results: A total of 959 (25.8%) out of 3,716 patients developed at least one late SVG occlusion. Significant risk factors for occlusion were female sex [beta coefficients (β) = 0.52], diabetes (β = 0.21), smoking (currently) (β = 0.32), hyperuricemia (β = 0.22), dyslipidemia (β = 0.52), prior percutaneous coronary intervention (PCI) (β = 0.21), a rising number of SVG (β = 0.12) and lesion vessels (β = 0.45). On-pump surgery (β = −0.46) and the use of angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) (β = −0.59) and calcium channel blockers (CCB) (β = −0.23) were protective factors. The risk scoring tool with 11 variables was developed from the derivation cohort, which delineated each patient into risk quartiles. The c-statistic for this model was 0.71 in the validation cohort.Conclusions: An easy-to-use risk scoring tool which included female sex, diabetes, smoking, hyperuricemia, dyslipidemia, prior PCI, a rising number of SVG and lesion vessels, on-pump surgery, the use of ACEI/ ARB and CCB was developed and validated. The scoring tool accurately estimated the risk of late SVG occlusion after CABG (c-statistic = 0.71). |
topic |
coronary artery bypass grafting coronary artery disease graft occlusion saphenous vein risk factor |
url |
https://www.frontiersin.org/articles/10.3389/fcvm.2021.670045/full |
work_keys_str_mv |
AT yujingcheng anovelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT xiaotengma anovelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT xiaoliliu anovelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT yingxinzhao anovelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT yansun anovelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT daizhang anovelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT qizhao anovelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT yingkaixu anovelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT yujiezhou anovelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT yujingcheng novelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT xiaotengma novelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT xiaoliliu novelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT yingxinzhao novelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT yansun novelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT daizhang novelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT qizhao novelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT yingkaixu novelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery AT yujiezhou novelriskscoringtooltopredictsaphenousveingraftocclusionaftercardiacarterybypassgraftsurgery |
_version_ |
1721209817445433344 |